Quest growth strategy
This article was originally published in The Rose Sheet
Executive Summary
Significant investments in people and creative and technical facilities will support global growth initiatives in 2007, fragrance manufacturer announces. Effort will include the opening of two specialized creative centers for personal and home care fragrance in Paris and Ashford, UK, respectively. The centers will bring "significant benefits" to the firm, including enhanced facilities, closer cooperation between fragrance teams and enhanced customer support capability, firm says. Quest also has appointed Francois Bousquet as VP global fine fragrance and Pierre Negrin as VP executive perfumer. Additionally, Olivier Pescheux and Christophe Raynaud have joined the firm as senior perfumers...
You may also be interested in...
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.